116 related articles for article (PubMed ID: 19338516)
1. Immunohistochemical profile of ephrin A4 expression in human osteosarcoma.
Abdou AG; Abd El-Wahed MM; Asaad NY; Samaka RM; Abdallaha R
APMIS; 2009 Apr; 117(4):277-85. PubMed ID: 19338516
[TBL] [Abstract][Full Text] [Related]
2. Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome.
Abdou AG; Abd el-Wahed MM; Asaad NY; Samaka RM; Abdallaha R
Indian J Cancer; 2010; 47(1):46-52. PubMed ID: 20071790
[TBL] [Abstract][Full Text] [Related]
3. Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.
Varelias A; Koblar SA; Cowled PA; Carter CD; Clayer M
Cancer; 2002 Aug; 95(4):862-9. PubMed ID: 12209731
[TBL] [Abstract][Full Text] [Related]
4. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
6. Distribution of integrins and their matrix ligands in osteogenic sarcomas.
Kawaguchi S; Uede T
J Orthop Res; 1993 May; 11(3):386-95. PubMed ID: 8326445
[TBL] [Abstract][Full Text] [Related]
7. De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway.
Fritsche-Guenther R; Noske A; Ungethüm U; Kuban RJ; Schlag PM; Tunn PU; Karle J; Krenn V; Dietel M; Sers C
Histopathology; 2010 Dec; 57(6):836-50. PubMed ID: 21166698
[TBL] [Abstract][Full Text] [Related]
8. Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding.
Moss A; Alvares D; Meredith-Middleton J; Robinson M; Slater R; Hunt SP; Fitzgerald M
Eur J Neurosci; 2005 Nov; 22(10):2413-21. PubMed ID: 16307584
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of N-cadherin and β-catenin protein in osteosarcoma].
Yang JZ; Zhang XH; Liu JR; Ding Y; Gao F; Wang Y
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):586-9. PubMed ID: 21122409
[TBL] [Abstract][Full Text] [Related]
10. Preliminary observation on the correlation between nm23 expression and Ki-67 antigen with early metastasis of human osteosarcoma.
Liao W; Chiu KY; Han S; Li F; Qiu J; Chow SP
Chin Med J (Engl); 1998 Sep; 111(9):813-7. PubMed ID: 11155673
[TBL] [Abstract][Full Text] [Related]
11. Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma.
Hernández-Rodríguez NA; Correa E; Sotelo R; Contreras-Paredes A; Gomez-Ruiz C; Green L; Mohar A
Cancer Detect Prev; 2001; 25(2):210-5. PubMed ID: 11341357
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein-3 in osteosarcomas and normal bone tissues.
Ressler S; Radhi J; Aigner T; Loo C; Zwerschke W; Sergi C
Anticancer Res; 2009 Jul; 29(7):2579-87. PubMed ID: 19596932
[TBL] [Abstract][Full Text] [Related]
13. The expression of CRM1 is associated with prognosis in human osteosarcoma.
Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of AR in osteosarcoma].
Liu J; Chen X; Li S; Yue X; Li Y
Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):344-5, 23. PubMed ID: 11832052
[TBL] [Abstract][Full Text] [Related]
15. Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma.
Yu L; Guo WC; Zhao SH; Tang J; Chen JL
APMIS; 2010 Mar; 118(3):222-9. PubMed ID: 20132188
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical examination of cytological differentiation in osteosarcomas.
Kawakami T; Shimizu T; Kimura A; Hasegawa H; Siar CH; Ng KH; Nagatsuka H; Nagai N; Kanda H
Eur J Med Res; 2005 Nov; 10(11):475-9. PubMed ID: 16354601
[TBL] [Abstract][Full Text] [Related]
17. [Protein expression of Skp2 in osteosarcoma and its relation with prognosis].
Liao QD; Zhong D; Chen Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):606-11. PubMed ID: 18667774
[TBL] [Abstract][Full Text] [Related]
18. Prevalent expression of MHC class I chain-related molecule A in human osteosarcoma.
Lu SM; Xiao P; Xue L; Che LH; Yang P; Li Y; Qiao H
Neoplasma; 2008; 55(3):266-72. PubMed ID: 18348660
[TBL] [Abstract][Full Text] [Related]
19. [Calcium concentration in osteosarcomas as 1 of the criteria of its malignancy].
Proshin VV
Vopr Onkol; 1977 Jan; 23(1):83-4. PubMed ID: 266308
[No Abstract] [Full Text] [Related]
20. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.
Lewis VO; Ozawa MG; Deavers MT; Wang G; Shintani T; Arap W; Pasqualini R
Cancer Res; 2009 Mar; 69(5):1995-9. PubMed ID: 19244100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
